. Author manuscript; available in PMC: 2016 Jan 29.

Published in final edited form as: Mol Diagn Ther. 2014 Dec;18(6):619–630. doi: 10.1007/s40291-014-0122-3

Table 1.

Clinical trials incorporating reverse phase protein microarray analysis.

Trial identifier^a	Acronym	Condition/Tumor type	Study design	Phase	Status
NCT01563874	N/A	Lymphoma	Observational	N/A	Completed
NCT00407810	N/A	Metastatic head and neck cancer	Open-label; interventional	II	Completed
NCT00867334	NITMEC	Colorectal cancer	Open-label; interventional	II	Completed
NCT01074814	Side-Out	Metastatic breast cancer	Open-label; interventional	II/III	Completed
NCT01919749	Side-Out 2	Metastatic breast cancer	Open-label; interventional	II/III	Recruiting
NCT01042379	I-SPY 2	Breast cancer	Open-label; interventional	II	Recruiting
NCT01023477	PINC	Breast-ductal carcinoma in situ	Open-label; interventional	I/II	Recruiting
NCT00798655	N/A	Head and neck cancer	Open-label; interventional	II	Recruiting
NCT02159989	N/A	Metastatic solid tumors	Open-label; interventional	I	Recruiting
NCT00897650	N/A	Lung cancer	Observational	N/A	Recruiting
NCT02133183	N/A	Adult Glioblastoma	Open-label; interventional	N/A	Recruiting

Clinicaltrials.gov identifier accessed from http://clinicaltrials.gov, provided by the U.S. National Library of Medicine, as of July 30, 2014.